Article
Morphological imaging of thymic disorders.
National Research Council (Center of Nuclear Medicine) and the Department of Biomorphological and Functional Sciences, University Federico II, Naples, Italy.
Annals of Medicine (impact factor:
3.52).
11/1999;
31 Suppl 2:57-62.
pp.57-62
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Updates in MRI characterization of the thymus in myasthenic patients.
[show abstract] [hide abstract]
ABSTRACT: To evaluate the imaging appearance of the thymus in the myasthenic patients by using chemical shift magnetic resonance imaging, and, to correlate the chemical shift ratio (CSR) with pathologic findings after surgical excision. In the past year, a total of 11 myasthenic patients (4 males, 7 females; age range of 26-65 years), have been investigated by MRI centered at the thymic lodge. Our protocol included a Dual-Echo technique, T1-weighted In-phase/Opposed-phase MR images in all patients. A chemical shift ratio (CSR) was calculated by comparing the signal intensity of the thymus gland with that of the chest wall muscle for quantitative analysis. For this purpose, we have used standard region-of-interest electronic cursors at a slice level of the maximum axial surface of the thymus. We have identified two patients groups: a thymic hyperplasia group and a thymic tumoral group. With the decrease in the signal intensity of the thymus gland at chemical shift, the MR imaging was evident only in the hyperplasia group. The mean CSR in the hyperplasia group was considerably lower than that in the tumor group, 0,4964 ± 0,1841, compared with 1,0398 ± 0,0244. The difference in CSR between the hyperplasia and tumor groups was statistically significant (P=0,0028). MR imaging using T1-weighted In-phase/Opposed-phase images could be a useful diagnostic tool in the preoperative assessment of the thymic lodge and may help differentiate thymic hyperplasia from tumors of the thymus gland.Journal of medicine and life 06/2012; 5(2):206-10.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
adjacent mediastinal fat
characterizes invasive thymomas
common neoplasms
detecting thymic hyperplasia
detecting thymomas
encapsulated thymoma
great vessels
invasive thymomas
magnetic resonance imaging
mediastinal fat
mediastinal masses
offering considerable aid
pericardial implants
primitive epithelial neoplasms
slight contrast enhancement
solid homogeneous mass
symmetric diffuse enlargement
T1-weighted MR scans
thymic hyperplasia
tumour mass